HealthEquity, Inc. (NASDAQ:HQY) Position Increased by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC grew its holdings in HealthEquity, Inc. (NASDAQ:HQYFree Report) by 96.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,941 shares of the company’s stock after acquiring an additional 3,908 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in HealthEquity were worth $580,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of HQY. Norges Bank bought a new stake in shares of HealthEquity in the fourth quarter valued at approximately $34,071,000. Clearbridge Investments LLC boosted its position in shares of HealthEquity by 23.5% in the second quarter. Clearbridge Investments LLC now owns 1,966,559 shares of the company’s stock valued at $124,169,000 after acquiring an additional 374,129 shares during the period. BlackRock Inc. lifted its position in HealthEquity by 4.0% in the first quarter. BlackRock Inc. now owns 9,423,008 shares of the company’s stock worth $635,488,000 after purchasing an additional 358,743 shares during the period. JPMorgan Chase & Co. lifted its position in HealthEquity by 15.5% in the first quarter. JPMorgan Chase & Co. now owns 2,474,430 shares of the company’s stock worth $145,273,000 after purchasing an additional 331,735 shares during the period. Finally, Franklin Resources Inc. lifted its position in HealthEquity by 23.4% in the second quarter. Franklin Resources Inc. now owns 1,445,385 shares of the company’s stock worth $91,262,000 after purchasing an additional 274,268 shares during the period. 98.46% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 2,499 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other HealthEquity news, EVP Delano Ladd sold 2,499 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the transaction, the executive vice president now owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Ian Sacks sold 45,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $63.50, for a total value of $2,857,500.00. Following the transaction, the director now directly owns 109,630 shares of the company’s stock, valued at approximately $6,961,505. The disclosure for this sale can be found here. In the last three months, insiders sold 52,102 shares of company stock valued at $3,379,812. 2.70% of the stock is owned by corporate insiders.

HealthEquity Stock Up 2.0 %

Shares of NASDAQ HQY opened at $79.61 on Monday. The firm’s 50-day simple moving average is $70.92 and its 200 day simple moving average is $70.09. The company has a market cap of $6.83 billion, a price-to-earnings ratio of 234.15, a price-to-earnings-growth ratio of 1.34 and a beta of 0.55. The company has a quick ratio of 4.93, a current ratio of 4.93 and a debt-to-equity ratio of 0.44. HealthEquity, Inc. has a 12-month low of $48.86 and a 12-month high of $80.22.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its quarterly earnings results on Tuesday, December 5th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.08. The company had revenue of $249.22 million during the quarter, compared to analysts’ expectations of $243.63 million. HealthEquity had a return on equity of 5.89% and a net margin of 3.00%. On average, research analysts expect that HealthEquity, Inc. will post 1.48 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on HQY. Barclays began coverage on HealthEquity in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $84.00 target price for the company. Raymond James raised their target price on HealthEquity from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 13th. Wells Fargo & Company raised their target price on HealthEquity from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 6th. JPMorgan Chase & Co. reduced their target price on HealthEquity from $81.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, December 1st. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $85.00 target price on shares of HealthEquity in a research report on Monday, December 4th. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.25.

Get Our Latest Report on HealthEquity

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.